文献速递头颈技术与安全US

超声靶向微泡空化局部递送miR-27a*抑制鳞状细胞癌生长

Local Delivery of miR-27a* Using Ultrasound-Targeted Microbubble Cavitation Inhibits Squamous Cell Carcinoma Growth.
PubMed 文献 · Ultrasound Med Biol · 2025-11-21

本研究在体外SCC-VII细胞和小鼠SCC-VII肿瘤模型中,利用超声靶向微泡空化(UTMC)递送miR-27a*,并与阴性对照微泡、静脉注射miR-27a*及未治疗组比较。结果显示miR-27a*-MB+UTMC显著降低体外细胞活力和体内肿瘤生长,并显著降低肿瘤中EGFR、NUP62和ΔNP63α蛋白表达50%-75%。作者认为UTMC可用于非侵入性递送寡核苷酸至血管外靶点,miR-27a*对头颈部鳞状细胞癌具有治疗潜力。

要点

  • UTMC递送miR-27a*可显著降低SCC-VII细胞活力和小鼠肿瘤生长。
  • miR-27a*-MB+UTMC使肿瘤EGFR、NUP62和ΔNP63α蛋白表达降低50%-75%。
  • 静脉注射miR-27a*未降低肿瘤中这些蛋白表达。

核心结论

  • UTMC可非侵入性递送寡核苷酸至血管外靶点,miR-27a*对头颈部鳞状细胞癌具有治疗潜力。

研究设计与样本

  • 体外SCC-VII细胞实验及SCC-VII小鼠肿瘤模型研究,比较miR-27a*-MB+UTMC、Con-miR-MB+UTMC、静脉注射miR-27a*和未治疗组。

临床应用与阅片要点

  • 作者认为UTMC可用于非侵入性递送寡核苷酸至血管外靶点。
  • 作者认为miR-27a*对头颈部鳞状细胞癌具有治疗潜力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Ultrasound-targeted microbubble (MB) cavitation (UTMC) is an image-guided therapeutic oligonucleotide delivery platform utilizing intravenously injected gas-filled ultrasound contrast agents, which carry the therapeutic on the MB shell. During transit of MBs in the microcirculation of target tissue, ultrasound causes MB oscillation, facilitating endocytosis-independent payload uptake within insonified cells. Here, we tested the hypothesis that UTMC-mediated miR-27a* delivery will reduce tumor growth rate and result in accumulation of miR-27a* within tumor cells and the tumor microenvironment.

METHODS: We used UTMC to deliver miR-27a* to SCC-VII cells in vitro and in SCC-VII mouse tumor models. Pulsed ultrasound was delivered during intravenous (i.v.) infusion of lipid encapsulated MBs loading either miR-27a* (miR-27a*-MB + UTMC) or negative control MBs (Con-miR-MB + UTMC).

RESULTS: miR-27a*-MB+UTMC treatment significantly reduced SCC-VII cell viability in vitro and SCC-VII tumor growth in vivo compared to negative controls (Con-miR-MB+UTMC, i.v. miR-27a* or no treatment). Forty-eight hours following treatment, protein expression of direct miR-27a* targets (epidermal growth factor receptor [EGFR], NUP62 and ΔNP63α) was significantly reduced in miR-27a*-MB + UTMC vs i.v. miR-27a* or Con-miR-MB + UTMC. Further, whereas i.v. miR-27a* did not decrease tumor expression of these proteins vs. non-treated tumors, miR-27a*-MB + UTMC significantly reduced tumor expression of EGFR, NUP62 and ΔNP63α by 50%-75%, compared to non-treated tumors.

CONCLUSION: These data substantiate the utility of UTMC for non-invasive delivery of oligonucleotide payloads to extravascular target sites and suggests the therapeutic potential of miR-27a* for the treatment of head and neck squamous cell carcinoma.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Chari NS, Chen C, Ramasamy T, et al. Local Delivery of miR-27a* Using Ultrasound-Targeted Microbubble Cavitation Inhibits Squamous Cell Carcinoma Growth. Ultrasound Med Biol. 2025. PMID: 41274844. doi:10.1016/j.ultrasmedbio.2025.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。